Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial

The University of Oxford’s Oxford Vaccine Group has today successfully vaccinated the first volunteer in the world’s first clinical trial of a vaccine designed to protect against Bundibugyo ebolavirus (BDBV).

MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit

The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.

Global study finds many countries are overusing powerful antibiotics while millions lack access to the medicines they need

Countries around the world are prescribing too many broad-spectrum antibiotics while millions of people still cannot access the medicines they need to treat serious infections, according to a new study led by researchers from City St George's, University of London and the University of Oxford's Nuffield Department of Primary Care Health Sciences.

Blood pressure-lowering benefits emerge early and do not build up over time

An analysis of data from more than 358,000 participants has found that the cardiovascular benefits of blood pressure-lowering treatment are established within months of starting therapy and do not progressively increase with longer treatment.

A third of adolescents have seen self-harm content online, despite most not looking for it – new Oxford study

One in three young people have seen self-harm content online in the course of the previous month, despite the majority not actively seeking it out, according to a major new study from the University of Oxford.

Can children shape their parents’ lives? Study suggests family influence flows both ways

Children’s characteristics may influence family dynamics over time, challenging the traditional view that influence flows primarily from parents to children, according to a new study.

Oxford-led newborn screening pilot expanded to include all babies in England

Every newborn baby in England will be screened for spinal muscular atrophy (SMA), following the expansion of a pioneering University of Oxford-led pilot that introduced the country’s first routine test for the condition.

Salsa classes shown to reduce depressive symptoms in young adults

A new trial led by the University of Oxford suggests it may offer a promising, accessible addition to youth wellbeing support.

Infections linked to higher risk of brain and mental health conditions for up to two years

A large study of more than 1 million matched patient pairs has found that serious infections across the body are followed by increased risks of psychiatric and neurological diagnoses, especially in adults.

Study shows AI can be safely deployed in NHS prostate cancer diagnosis

Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.

World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group

The University of Oxford’s Oxford Vaccine Group has launched the world’s first Phase I clinical trial, BD-Ebov, of a vaccine against Bundibugyo ebolavirus (BDBV), in response to the ongoing outbreak in the Democratic Republic of the Congo and neighbouring Uganda.

Researchers use OpenSAFELY to deliver first-ever large-scale analysis of Pharmacy First consultations in GP clinical systems

Conducting the first-ever, large-scale analysis of Pharmacy First consultations in GP records, researchers at the Bennett Institute for Applied Data Science, London School of Hygiene and Tropical Medicine, University of Nottingham, University of Manchester, and UKHSA used OpenSAFELY to analyse the programme’s service uptake, data quality, and integration into primary care systems.

World-first perfused pancreas transplant marks major Oxford study milestone

A clinical study at the University of Oxford has recruited its first participant, marking the world’s first successful transplantation of a perfused human pancreas and a major advance in efforts to improve organ preservation for transplantation.

Professor Adrian Hill wins European Inventor Award 2026 for highly effective malaria vaccine

The European Patent Office (EPO) has awarded Professor Sir Adrian Hill the European Inventor Award 2026 in the Research category for developing the R21/Matrix-M malaria vaccine.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences team wins Award for Excellence for transforming ulcerative colitis care

The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.

Patient enrolment begins in PARTNERS trial to identify the first effective treatments for Bundibugyo virus disease

Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from Médecins Sans Frontières (MSF). International trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.

Chellaram Foundation £5 million gift to Oxford launches new programme for healthy and sustainable diets

A major new research and engagement programme at the University of Oxford will investigate how healthier, more sustainable diets can be achieved at population level, and how evidence can inform policy and practice across food, health and environmental systems.

Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies

Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).

New Oxford calculator shows serious statin muscle side effects are rare for most people

Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new calculator that estimates a person's risk of developing serious muscle disorders from statins. The tool could help patients and clinicians make more informed decisions about using these widely prescribed medications to prevent heart attacks and strokes.

Smoking and drinking exacerbate social inequalities in premature deaths in India

Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.

Load More